Second consensus on medical treatment of metastatic breast cancer

被引：80

作者：

Beslija, S. ^{[1
]}

Bonneterre, J. ^{[1
]}

Burstein, H. ^{[1
]}

Cocquyt, V. ^{[1
]}

Gnant, M. ^{[1
]}

Goodwin, P. ^{[1
]}

Heinemann, V. ^{[1
]}

Jassem, J. ^{[1
]}

Koestler, W. J. ^{[1
]}

Krainer, M. ^{[1
]}

Menard, S. ^{[1
]}

Petit, T. ^{[1
]}

Petruzelka, L. ^{[1
]}

Possinger, K. ^{[1
]}

Schmid, P. ^{[1
]}

Stadtmauer, E. ^{[1
]}

Stockler, M. ^{[1
]}

Van Belle, S. ^{[1
]}

Vogel, C. ^{[1
]}

Wilcken, N. ^{[1
]}

Wiltschke, C. ^{[1
]}

Zielinski, C. C. ^{[1
]}

Zwierzina, H. ^{[1
]}

机构：

[1] CECOG, A-1090 Vienna, Austria

来源：

ANNALS OF ONCOLOGY | 2007年 / 18卷 / 02期

关键词：

chemotherapy; endocrine therapy; medical treatment; metastatic breast cancer; targeted therapy;

D O I：

10.1093/annonc/mdl155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.

引用

页码：215 / 225

页数：11

共 101 条

[51] Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials [J].

Klijn, JGM ;

Blamey, RW ;

Boccardo, F ;

Tominaga, T ;

Duchateau, L ;

Sylvester, R .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :343-353

[52] Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study [J].

Klijn, JGM ;

Beex, LVAM ;

Mauriac, L ;

van Zijl, JA ;

Veyret, C ;

Wildiers, J ;

Jassem, J ;

Piccart, M ;

Burghouts, J ;

Becquart, D ;

Seynaeve, C ;

Mignolet, F ;

Duchateau, L .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11) :903-911

[53] Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity [J].

Katsumasa Kuroi ;

Hiroko Bando ;

Shigehira Saji ;

Masakazu Toi .

Breast Cancer, 2003, 10 (1) :10-14

[54] Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study [J].

Leyland-Jones, B ;

Semiglazov, V ;

Pawlicki, M ;

Pienkowski, T ;

Tjulandin, S ;

Manikhas, G ;

Makhson, A ;

Roth, A ;

Dodwell, D ;

Baselga, J ;

Biakhov, M ;

Valuckas, K ;

Voznyi, E ;

Liu, XY ;

Vercammen, E .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5960-5972

[55] Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel [J].

Leyland-Jones, B ;

Gelmon, K ;

Ayoub, JP ;

Arnold, A ;

Verma, S ;

Dias, R ;

Ghahramani, P .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3965-3971

[56] Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial [J].

Lonning, PE ;

Bajetta, E ;

Murray, R ;

Tubiana-Hulin, M ;

Eisenberg, PD ;

Mickiewicz, E ;

Celio, L ;

Pitt, P ;

Mita, M ;

Aaronson, NK ;

Fowst, C ;

Arkhipov, A ;

di Salle, E ;

Polli, A ;

Massimini, G .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2234-2244

[57] A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer [J].

Lyman, GH ;

Green, SJ ;

Ravdin, PM ;

Geyer, CE ;

Russell, CA ;

Balcerzak, SP ;

Budd, GT ;

Martino, S .

BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (02) :143-150

[58] Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials [J].

Major, P ;

Lortholary, A ;

Hon, J ;

Abdi, E ;

Mills, G ;

Menssen, HD ;

Yunus, F ;

Bell, R ;

Body, J ;

Quebe-Fehling, E ;

Seaman, J .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :558-567

[59] Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:: The M77001 study group [J].

Marty, M ;

Cognetti, F ;

Maraninchi, D ;

Snyder, R ;

Mauriac, L ;

Tubiana-Hulin, M ;

Chan, S ;

Grimes, D ;

Antón, A ;

Lluch, A ;

Kennedy, J ;

O'Byrne, K ;

Conte, P ;

Green, M ;

Ward, C ;

Mayne, K ;

Extra, JM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4265-4274

[60]

Mass Robert D, 2005, Clin Breast Cancer, V6, P240, DOI 10.3816/CBC.2005.n.026

← 1 2 3 4 5 6 7 8 9 10 →